Bridgeway Capital Management’s Endologix Inc ELGX Stock Holding History

Bridgeway Capital Management’s Portfolio ELGX Stock Details ELGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-199,600	Closed	-$160K	–	1405
2020 Q2	$160K	Buy	199,600 +130,000	+187%	+$110K	﹤0.01%	1180
2020 Q1	$48K	Sell	69,600 -18,200	-21%	-$22.3K	﹤0.01%	1229
2019 Q4	$139K	Buy	87,800 +47,800	+120%	+$134K	﹤0.01%	1232
2019 Q3	$159K	Buy	40,000 +30,000	+300%	+$174K	﹤0.01%	1210
2019 Q2	$72K	Hold	10,000	–	–	﹤0.01%	1265
2019 Q1	$66K	Sell	10,000 -27,500	-73%	-$181K	﹤0.01%	1302
2018 Q4	$269K	Buy	+37,500	New	+$418K	﹤0.01%	1161

Other funds holding ELGX

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Bridgeway Capital Management's ELGX Position: Q3 2020 in Review

Bridgeway Capital Management sold out of Endologix Inc (ELGX) in Q3 2020, closing a stake of 199,600 shares — an estimated $160K sold.

Bridgeway Capital Management first reported a position in ELGX in Q4 2018 and held it in 7 quarters. The position peaked at $269K in Q4 2018. 6 funds tracked by Wall St. Rank hold ELGX as of Q3 2020.

Bridgeway Capital Management reported no remaining Endologix Inc position as of Q3 2020 after selling out during the quarter.
Bridgeway Capital Management sold 199,600 Endologix Inc shares in Q3 2020, an estimated $160K.
Bridgeway Capital Management first reported a position in Endologix Inc in Q4 2018 and held it in 7 quarters.
Bridgeway Capital Management's Endologix Inc position peaked at $269K in Q4 2018.
6 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2020.

Based on Bridgeway Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.